Stay updated on MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial
Sign up to get notified when there's something new on the MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial page.

Latest updates to the MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This appears to be a minor metadata update with no changes to study content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check40 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1, with no visible changes to the Study Details content or core page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a glossary toggle (Show glossary) and a new QC update label 'Last Update Submitted that Met QC Criteria' (replacing the previous 'Last Update Submitted that met QC Criteria'). Updated the No FEAR Act notice to 'No FEAR Act data' and the page revision from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page revision indicator has been updated to v3.3.4 (replacing v3.3.3); no study content or user interactions are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedLocations section added and Mexico City is listed as a study site. The previous Mexico City Locations entry was removed, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

Stay in the know with updates to MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo vs Docetaxel Alone in NSCLC Clinical Trial page.